Movement Alert｜WUXI BIO Falls 3.02% in Regular Trading, CXO Sector Retreat Weighs on Sentiment

Market Focus

10 hours ago

On October 7, WUXI BIO fell 3.02% in regular trading, trading at 56.05 HKD/share, with Turnover of 2.61 billion HKD.

The decline comes after a 3.16% intraday gain the previous day, indicating short-term profit-taking pressure. The broader CXO sector also traded lower, with GENSCRIPT BIO down 14.0%, INSILICO down 8.18%, XTALPI down 5.96%, PHARMARON down 3.7%, and WUXI APPTEC down 1.28%. Despite WUXI BIO's previously reported strong interim results—revenue of 11.787 billion RMB, adjusted net profit of 3.937 billion RMB, and a gross margin improvement to 46.2%—and the cancellation of 39.8245 million repurchased shares, sector-wide weakness dominated trading sentiment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1166320821"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1166320821\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1166320821?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-07 09:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1166320821","market":"us","top_or_hot":-1,"title":"Movement Alert｜WUXI BIO Falls 3.02% in Regular Trading, CXO Sector Retreat Weighs on Sentiment","media":"Market Focus","content":"<p><p>On October 7, WUXI BIO fell 3.02% in regular trading, trading at 56.05 HKD/share, with Turnover of 2.61 billion HKD.</p><p>The decline comes after a 3.16% intraday gain the previous day, indicating short-term profit-taking pressure. The broader CXO sector also traded lower, with GENSCRIPT BIO down 14.0%, INSILICO down 8.18%, XTALPI down 5.96%, PHARMARON down 3.7%, and WUXI APPTEC down 1.28%. Despite WUXI BIO's previously reported strong interim results—revenue of 11.787 billion RMB, adjusted net profit of 3.937 billion RMB, and a gross margin improvement to 46.2%—and the cancellation of 39.8245 million repurchased shares, sector-wide weakness dominated trading sentiment.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜WUXI BIO Falls 3.02% in Regular Trading, CXO Sector Retreat Weighs on Sentiment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜WUXI BIO Falls 3.02% in Regular Trading, CXO Sector Retreat Weighs on Sentiment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-10-07 09:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On October 7, WUXI BIO fell 3.02% in regular trading, trading at 56.05 HKD/share, with Turnover of 2.61 billion HKD.</p><p>The decline comes after a 3.16% intraday gain the previous day, indicating short-term profit-taking pressure. The broader CXO sector also traded lower, with GENSCRIPT BIO down 14.0%, INSILICO down 8.18%, XTALPI down 5.96%, PHARMARON down 3.7%, and WUXI APPTEC down 1.28%. Despite WUXI BIO's previously reported strong interim results—revenue of 11.787 billion RMB, adjusted net profit of 3.937 billion RMB, and a gross margin improvement to 46.2%—and the cancellation of 39.8245 million repurchased shares, sector-wide weakness dominated trading sentiment.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02269","symbol_name":"药明生物","start_time":0,"source_url":"","article_id":"1166320821","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1166320821","pubTimestamp":1791336840,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On October 7, WUXI BIO fell 3.02% in regular trading, trading at 56.05 HKD/share, with Turnover of 2.61 billion HKD.The decline comes after a 3.16% intraday gain the previous day, indicating...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02269":"药明生物"},"translate_title":"走势提醒|药明生物常规交易下跌3.02%，CXO板块回调打压市场情绪","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02269":1},"content_text":"On October 7, WUXI BIO fell 3.02% in regular trading, trading at 56.05 HKD/share, with Turnover of 2.61 billion HKD.The decline comes after a 3.16% intraday gain the previous day, indicating short-term profit-taking pressure. The broader CXO sector also traded lower, with GENSCRIPT BIO down 14.0%, INSILICO down 8.18%, XTALPI down 5.96%, PHARMARON down 3.7%, and WUXI APPTEC down 1.28%. Despite WUXI BIO's previously reported strong interim results—revenue of 11.787 billion RMB, adjusted net profit of 3.937 billion RMB, and a gross margin improvement to 46.2%—and the cancellation of 39.8245 million repurchased shares, sector-wide weakness dominated trading sentiment.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}